Mortality and Hospital Readmission in Patients with Methamphetamine-associated Cardiomyopathy
Conference Paper
Overview
Research
Identity
Additional Document Info
View All
Overview
abstract
Patients with methamphetamine-associated cardiomyopathy (MACM), a dilated cardiomyopathy, have significant myocardial damage. In this study, we assess whether patients with MACM have a higher mortality and hospital readmission at 1-year follow-up than patients with idiopathic dilated cardiomyopathy (IDCM) without methamphetamine use.
